For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and the formulated version represents a significant change. These innovative therapies stabilize the transthyretin protein, preventing its harmful build-up and alleviating